RHYTHM PHARMACEUTICALS, INC. (RYTM)
RHYTHM PHARMACEUTICALS, INC. filed 56 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 122 transactions and 807,614 shares. None carries the SEC's AFF10B5ONE flag; all 56 name a plan in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-14, came 13 days after the one before it (2026-09-01) and reports 7 transactions against 5 in the filing before it.
- The sales it reports total 50,000 shares, 12,774 fewer than the 62,774 in the filing before it.
- Its 56 plan statements rank 88th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 56 filings on file run from 2025-02-04 to 2026-09-14, and state 13 plan adoption dates, from 2023-02-27 to 2026-06-15.
Trades in RHYTHM PHARMACEUTICALS, INC. 122
- Cramer Pamela J. — 2025-02-04 · S · 902 shares
- Lee Jennifer Kayden — 2025-02-04 · S · 1,447 shares
- Meeker David P — 2025-02-04 · S · 4,278 shares
- Shulman Joseph — 2025-02-04 · S · 1,281 shares
- Smith Hunter C — 2025-02-04 · S · 1,678 shares
- Lee Jennifer Kayden — 2025-02-05 · S · 1,733 shares
- Lee Jennifer Kayden — 2025-02-05 · S · 1,133 shares
- Lee Jennifer Kayden — 2025-02-05 · S · 200 shares
- Lee Jennifer Kayden — 2025-02-10 · S · 1,894 shares
- Lee Jennifer Kayden — 2025-02-10 · S · 2,295 shares
- Cramer Pamela J. — 2025-02-11 · S · 698 shares
- Cramer Pamela J. — 2025-02-11 · S · 3 shares
Adoption dates in RHYTHM PHARMACEUTICALS, INC. 13
- 2023-02-27 — stated in 16 filings
- 2024-06-25 — stated in 1 filing
- 2024-08-08 — stated in 9 filings
- 2024-12-13 — stated in 3 filings
- 2024-12-16 — stated in 4 filings
- 2025-02-28 — stated in 7 filings
- 2025-03-03 — stated in 1 filing
- 2025-03-11 — stated in 3 filings
- 2025-08-07 — stated in 3 filings
- 2025-12-15 — stated in 2 filings
- 2026-05-13 — stated in 2 filings
- 2026-05-14 — stated in 2 filings
Results prints in RHYTHM PHARMACEUTICALS, INC. 9
- 2025-01-10
- 2025-02-26
- 2025-05-07
- 2025-08-05
- 2025-11-04
- 2026-01-09
- 2026-02-26
- 2026-05-05
- 2026-08-04
Trades before a print in RHYTHM PHARMACEUTICALS, INC. 1
- 5 days before the 2025-11-04 print — 2025-10-30 · S · Shulman Joseph · 9,748 shares
- 7 days before the 2025-02-26 print — 2025-02-19 · S · Cramer Pamela J. · 982 shares
- 7 days before the 2025-02-26 print — 2025-02-19 · S · German Christopher Paul · 635 shares
- 7 days before the 2025-02-26 print — 2025-02-19 · S · Lee Jennifer Kayden · 2,035 shares
- 7 days before the 2025-02-26 print — 2025-02-19 · S · Meeker David P · 9,896 shares
- 7 days before the 2025-02-26 print — 2025-02-19 · S · Shulman Joseph · 1,228 shares
- 7 days before the 2025-02-26 print — 2025-02-19 · S · Smith Hunter C · 2,215 shares
- 7 days before the 2025-08-05 print — 2025-07-29 · S · Cramer Pamela J. · 1,520 shares
- 7 days before the 2025-11-04 print — 2025-10-28 · S · Shulman Joseph · 2,815 shares
- 7 days before the 2026-02-26 print — 2026-02-19 · S · Smith Hunter C · 1,308 shares
- 7 days before the 2026-02-26 print — 2026-02-19 · S · Smith Hunter C · 1,692 shares
- 7 days before the 2026-02-26 print — 2026-02-19 · S · Smith Hunter C · 800 shares
Interval to RHYTHM PHARMACEUTICALS, INC.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 20within 10 days
- 5shortest, days
- 20no later print
- Cramer Pamela J. 2025-02-19 · S · 7 days before the 2025-02-26 print · Chief Human Resources Officer
- German Christopher Paul 2025-02-19 · S · 7 days before the 2025-02-26 print · Corporate Controller & CAO
- Lee Jennifer Kayden 2025-02-19 · S · 7 days before the 2025-02-26 print · EVP, Head of North America
- Meeker David P 2025-02-19 · S · 7 days before the 2025-02-26 print · President and CEO
- Shulman Joseph 2025-02-19 · S · 7 days before the 2025-02-26 print · Chief Technical Officer
- Smith Hunter C 2025-02-19 · S · 7 days before the 2025-02-26 print · Chief Financial Officer
- Cramer Pamela J. 2025-04-29 · S · 8 days before the 2025-05-07 print · Chief Human Resources Officer
- Mazabraud Yann 2025-04-29 · S · 8 days before the 2025-05-07 print · EVP, Head of International
- Cramer Pamela J. 2025-07-29 · S · 7 days before the 2025-08-05 print · Chief Human Resources Officer
- Shulman Joseph 2025-10-28 · S · 7 days before the 2025-11-04 print · Chief Technical Officer
- Shulman Joseph 2025-10-30 · S · 5 days before the 2025-11-04 print · Chief Technical Officer
- Smith Hunter C 2026-02-17 · S · 9 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-17 · S · 9 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-17 · S · 9 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-17 · S · 9 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-17 · S · 9 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-19 · S · 7 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-19 · S · 7 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-19 · S · 7 days before the 2026-02-26 print · Chief Financial Officer
- Smith Hunter C 2026-02-19 · S · 7 days before the 2026-02-26 print · Chief Financial Officer
Adoption dates RHYTHM PHARMACEUTICALS, INC. states
- 2023-02-27 in 16 filings
- 2024-06-25 in 1 filing
- 2024-08-08 in 9 filings
- 2024-12-13 in 3 filings
- 2024-12-16 in 4 filings
- 2025-02-28 in 7 filings
- 2025-03-03 in 1 filing
- 2025-03-11 in 3 filings
- 2025-08-07 in 3 filings
- 2025-12-15 in 2 filings
- 2026-05-13 in 2 filings
- 2026-05-14 in 2 filings
- 2026-06-15 in 1 filing
Filing text: “10b5-1 instruction adopted prior to February 27, 2023”
Reported results dates on file
- 2025-01-10
- 2025-02-26
- 2025-05-07
- 2025-08-05
- 2025-11-04
- 2026-01-09
- 2026-02-26
- 2026-05-05
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
RHYTHM PHARMACEUTICALS, INC.’s insider trading plan record — 56 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001649904.